ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 711,61
0,34%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. NexGel Inc (NXGL)

  7. NexGel Inc (NXGL) Actualités

NXGL NexGel Inc

2,08
0,02 (0,97%)
01 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
NexGel Inc NXGL NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,02 0,97% 2,08 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
2,15 2,105 2,15 2,08 2,06
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
16/5/202415:00GLOBENEXGEL Acquires International Beauty Brand, Silly George
13/5/202422:05GLOBENEXGEL Reports First Quarter 2024 Revenue of $1.27 Million,..
09/5/202414:00GLOBENEXGEL to Report First Quarter 2024 Financial Results on May..
06/5/202422:05GLOBENEXGEL to Present at the Aegis Capital Virtual Conference on..
18/4/202414:00GLOBENEXGEL to Present at the Planet MicroCap Showcase: VEGAS..
01/4/202413:50GLOBENEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an..
27/3/202414:00GLOBENEXGEL Reschedules Fourth Quarter and Full Year 2023..
21/3/202414:00GLOBENEXGEL to Report Fourth Quarter and Full Year 2023 Financial..
05/3/202415:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202414:30GLOBENEXGEL to Present at the iAccess Alpha Best Ideas Spring..
21/2/202422:17EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
21/2/202422:15EDGAR2Form 8-K - Current report
21/2/202422:05GLOBENEXGEL Announces $975,000 Registered Direct Offering Led by..
31/1/202415:05EDGAR2Form 8-K - Current report
18/1/202415:00GLOBENEXGEL to Present at The Microcap Conference, January 30th..
16/1/202422:30EDGAR2Form 8-K - Current report
09/1/202414:30GLOBENEXGEL Subsidiary, CG Converting and Packaging, Begins..
29/12/202322:30EDGAR2Form 8-K - Current report
26/12/202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202322:52EDGAR2Form 8-K - Current report
11/12/202314:15EDGAR2Form 8-K - Current report
11/12/202314:00GLOBENEXGEL Announces Partnership with STADA to Distribute and..
05/12/202314:10EDGAR2Form 8-K - Current report
05/12/202314:00GLOBENEXGEL Acquires Kenkoderm Psoriasis Skincare Line
13/11/202323:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202323:10EDGAR2Form 8-K - Current report
13/11/202322:05GLOBENEXGEL Reports Record Third Quarter 2023 Revenue of $1.2..
02/11/202314:00GLOBENEXGEL to Report Third Quarter 2023 Financial Results on..
30/10/202313:30EDGAR2Form 8-K - Current report
30/10/202313:00GLOBENEXGEL Secures Supply Agreement with AbbVie
26/9/202315:49GLOBENEXGEL to Participate in the LD Micro Main Event XVI on..
15/9/202300:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/8/202300:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202322:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202322:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202322:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202323:29EDGAR2Form 8-K - Current report
14/8/202322:39EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202322:05GLOBENEXGEL Reports Second Quarter 2023 Record Revenue of $1.17..
02/8/202315:00GLOBENEXGEL to Report Second Quarter 2023 Financial Results on..
19/7/202315:10GLOBENEXGEL Partners with Enigma Health to Distribute its Leading..
15/6/202315:00GLOBENEXGEL to Participate in Maxim Group’s Virtual Healthcare..

Dernières Valeurs Consultées

NASDAQ
NXGL
NexGel
NASDAQ
VRZST
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés